Resmed (RSMDF) Non Operating Income (2009 - 2026)
Resmed's (RSMDF) quarterly Non Operating Income came in at $25.5 million in Q2 2026, up 624.51% on a YoY basis from $3.5 million in Q2 2025, and up 917.27% quarter-over-quarter from $2.5 million in Q1 2026.
Analysis
Resmed (RSMDF) Non Operating Income (2009 - 2026) Analysis & Trends
Resmed (RSMDF) has reported Non Operating Income for 18 consecutive years, with $25.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Income rose 624.51% year-over-year to $25.5 million; the trailing twelve-month figure through Jun 2026 stood at $32.7 million (up 519.31% YoY), and the FY2026 full-year result was $32.7 million, up 519.4% from the prior year.
- Non Operating Income grew to $25.5 million in Q2 2026 per RSMDF's latest filing, from $2.5 million in the prior quarter.
- Across five years, Non Operating Income topped out at $25.5 million in Q2 2026 and bottomed at -$23.5 million in Q2 2024.
- Historically, Non Operating Income has averaged -$4.8 million across 5 years, with a median of -$5.2 million in 2022.
- The sharpest annual moves came in 2024 and 2026: Non Operating Income slumped 1631.9% in 2024, then jumped 624.51% in 2026.
- Over 5 years, Non Operating Income stood at -$6.5 million in 2022, then slumped by 140.5% to -$15.6 million in 2023, then soared by 106.9% to $1.1 million in 2024, then soared by 315.94% to $4.5 million in 2025, then soared by 467.11% to $25.5 million in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $25.5 million, $2.5 million, and $4.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 185.05 Bn | 179.45 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.43 Bn | 119.22 Bn | 1.96 Bn | 82.70 Mn |
| 3 | Medtronic | 118.52 Bn | 109.70 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.55 Bn | 101.07 Bn | 4.50 Bn | 46.00 Mn |
| 5 | Boston Scientific | 67.11 Bn | 66.57 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.85 Bn | 45.60 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 33.97 Bn | 32.52 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn | - |
| 9 | Steris | 21.15 Bn | 20.67 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 25.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.45 Mn |
| Mar 31, 2026 | 2.50 Mn |
| Dec 31, 2025 | 4.49 Mn |
| Sep 30, 2025 | 256,000.00 |
| Jun 30, 2025 | 3.51 Mn |
| Mar 31, 2025 | -8.58 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | -3.82 Mn |
| Jun 30, 2024 | -23.48 Mn |
| Mar 31, 2024 | 837,000.00 |
| Dec 31, 2023 | -15.64 Mn |
| Sep 30, 2023 | -16.81 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | -11.29 Mn |
| Dec 31, 2022 | -6.50 Mn |
| Sep 30, 2022 | -13.95 Mn |
| Jun 30, 2022 | -17.31 Mn |
| Mar 31, 2022 | -7.95 Mn |
| Dec 31, 2021 | -11.43 Mn |
| Sep 30, 2021 | -3.13 Mn |